By Jennifer Jones, M.S.
Biosimilar Antibodies: Imitation Meets Innovation
In the ever-evolving medical landscape, a new class of pharmaceuticals is emerging as a game-changer, poised to transform the way we approach treatment options: Biosimilars. Biosimilars are biologics, such as antibodies and proteins, that demonstrate therapeutic equivalency to the original approved drug, also known as the reference product. The...